Product Information
LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0999 per EA under NDC 00480872598. Its NADAC has been published 195 times since Nov 30, 2022.
FDA first approved this application on May 10, 2022. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480872598
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207588FDA Approved
5/10/2022
TE Code
AB1,AB2,AB3,AB4
On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 195 times since Nov 30, 2022, and over the history we have for it it has declined 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0999 per EA |
|---|---|
| All-time high | $0.1821 (Jul 12, 2023) |
| All-time low | $0.0715 (Jul 17, 2024) |
| 52-week high | $0.1278 |
| 52-week low | $0.0999 |
| Median price | $0.1247 |
| Average price | $0.1274 |
| Largest weekly change | +78.9% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0999 per EA (NDC 00480872598), effective Aug 19, 2026.
How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 22.5%. It has been tracked across 195 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?
Since Nov 30, 2022, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.1821 (Jul 12, 2023), with a median of $0.1247 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 300 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 300 MCG TABLET?
LEVOTHYROXINE 300 MCG TABLET (NDC 00480872598) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.